In financial accounting, a balance sheet is a summary of the financial balances of an individual or organization, whether it be a sole proprietorship, a business partnership, a corporation, private limited company or other organization such as government or not-for-profit entity.
Bioxyne Limited Balance Sheet Statement - Assets
As of 30 Jun 2024, The total current assets of Bioxyne Limited (ASX:BXN) was around $5,585,085 which consisted of $1,027,989 of Cash, $2,141,923 of Inventory and $1,110,821 of Net receivables. Current assets represent all the assets of a company that are expected to be conveniently sold, consumed, used, or exhausted through standard business operations within one year.
All amounts in AUD
The latest balance sheet of Bioxyne Limited also showed $824,073 of Property Plant Equipment and $288,476 of Good will. Also there were no Intangible assets and no Other assets. The total assets including current and Intangibles/Deferred Long Term Asset Charges were $6,697,634.
Bioxyne Limited Balance Sheet Statement - Liabilities
BXN's latest annual results shows the balance sheet has $1,192,864 of Accounts Payable. Also there were $673,723 of Short/Long term debt, no Long term debt, no Other Current liabilities and $2,907,351 of Total Current Liabilities. Current liabilities are a company's short-term financial obligations that are due within one year or within a normal operating cycle.
As per the 30 Jun 2024's annual report of Bioxyne Limited, the total liabilities were $3,398,078.
BXN Balance Sheet Statement - Stock Holder Equity
Stockholders' equity, also referred to as shareholders' equity, is the remaining amount of assets available to shareholders after all liabilities have been paid. It is calculated either as a firm's total assets less its total liabilities or alternatively as the sum of share capital and retained earnings less treasury shares. Stockholders' equity might include common stock, paid-in capital, retained earnings and treasury stock.
The latest Balance sheet of Bioxyne Limited showed the total stock holder equity was $3,606,224 which consisted of $18,997,751 of Common stocks, $-15,595,471 of Retained earnings and no Other stock holder equity.
BXN Balance Sheet Statement History
Following table shows the history of balance sheet for Bioxyne Limited (BXN).
| 30 Jun 2024 | 30 Jun 2023 | 30 Jun 2022 | 30 Jun 2021 | |
|---|---|---|---|---|
| Cash | 1,027,989 | 3,845,969 | 2,168,009 | 1,602,210 |
| Net Receivables | 1,110,821 | 897,971 | 17,848 | 335,334 |
| Inventory | 2,141,923 | 994,806 | 310,230 | 439,517 |
| Total Current Assets | 5,585,085 | 6,040,089 | 2,817,943 | 2,580,413 |
| Property Plant Equipment | 824,073 | 85,024 | 74,649 | 137,888 |
| Good Will | 288,476 | 11,568,010 | - | - |
| Intangible Assets | - | - | 30,269 | 30,269 |
| Other Assets | - | - | - | - |
| Deferred Long Term Asset Charges | - | - | - | - |
| Total Assets | 6,697,634 | 17,693,123 | 2,922,861 | 2,748,570 |
| Accounts Payable | 1,192,864 | 1,205,254 | 95,102 | 175,658 |
| Short/Long Term Debt | 673,723 | - | - | - |
| Other Current Liabilities | - | - | - | - |
| Long Term Debt | - | - | - | - |
| Other Liabilities | - | - | - | - |
| Total Current Liabilities | 2,907,351 | 2,686,988 | 981,510 | 744,748 |
| Total Liabilities | 3,398,078 | 2,686,988 | 981,510 | 744,748 |
| Common Stock | 18,997,751 | 17,547,751 | 62,177,536 | 62,177,536 |
| Retained Earnings | -15,595,471 | -2,483,750 | -60,477,334 | -60,170,826 |
| Treasury Stock | - | - | - | - |
| Other Stockholder Equity | - | - | - | - |
| Total Stockholder Equity | 3,606,224 | 15,137,130 | 1,888,490 | 1,950,961 |
| Net Tangible Assets | 3,317,748 | 3,569,120 | 1,858,221 | 1,920,692 |
Bioxyne Limited (ASX:BXN) Balance Sheet Statement FAQ
1. How much Cash Bioxyne Limited has on their balance sheet?
As of 30 Jun 2024, Bioxyne Limited (ASX:BXN) has $1,027,989 of Cash.
2. What's the long term debt of Bioxyne Limited?
As per the latest Balance sheet of Bioxyne Limited (ASX:BXN), it has no Long term debt.
3. How much share holder equity does Bioxyne Limited has?
The Bioxyne Limited (ASX:BXN)'s balance sheet shows that it has $3,606,224 of Total stock holder equity.